Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias

4 Issues per year


CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

Online
ISSN
1553-3840
See all formats and pricing
More options …

Medicinal plants’ use among patients with dyslipidemia: an Iranian cross-sectional survey

Mohammad Hashem Hashempur
  • Department of Persian Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran (Islamic Republic of)
  • Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Seyed Hamdollah Mosavat
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mojtaba Heydari
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mesbah Shams
  • Corresponding author
  • Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-11-03 | DOI: https://doi.org/10.1515/jcim-2018-0101

Abstract

Background

Despite growing demand for medicinal plants, there is little data about their use by patients with dyslipidemia. We aimed to determine the prevalence, pattern, and associated factors for the use of medicinal plants among patients with dyslipidemia.

Methods

A 17-item semi-structured questionnaire was filled out by 195 patients with dyslipidemia in a cross-sectional study carried out in two academic endocrinology clinics in Shiraz, Iran. The questionnaire comprised of three main domains of demographic data (6 questions), clinical data (2 of them), and data related to the use of medicinal plants (totally 9 questions).

Results

A total of 77.4% of patients took medicinal plants. The most common medicinal herbs used by dyslipidemic patients were Zataria multiflora, Cinnamomum zeylanicum, and Zingiber officinale. Duration of dyslipidemia was significantly longer in herbal users than non-herbal users (p=0.04). Patients believing that concomitant use of conventional drugs and herbal preparations had synergic positive effects in addition to those persuaded that herbal preparations possessed less side effects, were significantly more likely to use medicinal plants (p=0.008 and 0.005, respectively). Additionally, most of the medicinal herb users (87.4%) changed neither the pattern nor the dosage of their medications all during herbal preparations use.

Conclusions

This study demonstrated a high prevalence of medicinal plants’ use among patients with dyslipidemia, which was associated with the duration of dyslipidemia, patients’ viewpoints about herbal preparations’ synergic positive effects, and their fewer side effects.

Keywords: complementary therapies; dyslipidemia; medicinal plants; phytotherapy; prevalence; traditional Persian medicine

References

  • [1]

    de Sereday MS, Gonzalez C, Giorgini D, De Loredo L, Braguinsky J, Cobenas C, et al. Prevalence of diabetes, obesity, hypertension and dyslipidemia in the central area of Argentina. Diabetes Metab 2004;30:335–9.Google Scholar

  • [2]

    Ruixing Y, Fengping H, Shangling P, Dezhai Y, Weixiong L, Tangwei L, et al. Prevalence of dyslipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. J Investig Med 2006;54:191–200.Google Scholar

  • [3]

    Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med 2014;5:373–93.Google Scholar

  • [4]

    Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia prevalence in Iranian adult men: the impact of population-based screening on the detection of undiagnosed patients. World J Mens Health 2015;33:167–73.Google Scholar

  • [5]

    Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, et al. Prevalence of obesity, type II diabetes mellitus, dyslipidemia, and hypertension in the United States: findings from the GE centricity electronic medical record database. Popul Health Manag 2010;13:151–61.Google Scholar

  • [6]

    Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 2007;7:32.Google Scholar

  • [7]

    Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord 2013;12:49.Google Scholar

  • [8]

    World Health Organization. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization, 2002.Google Scholar

  • [9]

    Wilkinson JM, Stevens MJ. Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre. J Complement Integr Med 2014;11:139–45.Google Scholar

  • [10]

    Jabbari M, Daneshfard B, Emtiazy M, Khiveh A, Hashempur MH. Biological effects and clinical applications of Dwarf Elder (Sambucus ebulus L): a review. J Evid Based Complementary Altern Med 2017;22:996–1001.Google Scholar

  • [11]

    Lee G, Charn T, Chew Z, Ng T. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004;21:654–60.Google Scholar

  • [12]

    Hasan SS, Ahmed SI, Bukhari NI, Loon WC. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15:152–7.Google Scholar

  • [13]

    Wazaify M, Alawwa I, Yasein N, Al-Saleh A, Afifi FU. Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract 2013;19:153–7.Google Scholar

  • [14]

    Bregum F. The present status of medicinal plants in Bangladesh. Iran J Pharm Res 2010;3:34.Google Scholar

  • [15]

    Tangkiatkumjai M, Boardman H, Walker DM. Herbal and dietary supplement use in Bangkok: a survey. J Complement Integr Med 2014;11:203–11.Google Scholar

  • [16]

    Akrami R, Hashempur MH, Tavakoli A, Nimrouzi M, Sayadi M, Roodaki M, et al. Effects of Fumaria parviflora L on uremic pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Jundishapur J Nat Pharm Prod 2017;12:e39744.Google Scholar

  • [17]

    Spinks J, Johnston D, Hollingsworth B. Complementary and alternative medicine (CAM) use and quality of life in people with type 2 diabetes and/or cardiovascular disease. Complement Ther Med 2014;22:107–15.Google Scholar

  • [18]

    Dehghan M, Mokhtarabadi S, Heidari FG. Complementary and alternative medicine usage and its determinant factors among Iranian infertile couples. J Complement Integr Med 2018;15. DOI: CrossrefGoogle Scholar

  • [19]

    Organisation mondiale de la santé. WHO global atlas of traditional, complementary and alternative medicine. Geneva: World Health Organization, 2005.Google Scholar

  • [20]

    Cheraghali AM Herbal medicine in the Islamic Republic of Iran. World Health Organization. 2016;4: 14. Available at: http://apps.who.int/medicinedocs/en/d/Js4923e/3.5.html#Js4923e.3.5

  • [21]

    Hooper D, Field H, Dahlgren BE Useful plants and drugs of Iran and Iraq. Field Museum of Natural History. 1937.Google Scholar

  • [22]

    Nowbandegani AS, Kiumarcy S, Rahmani F, Dokouhaki M, Khademian S, Zarshenas MM, et al. Ethnopharmacological knowledge of shiraz and Fasa in Fars region of Iran for diabetes mellitus. J Ethnopharmacol 2015;172:281–7.Google Scholar

  • [23]

    Hassanzade Ajiri D Herbal life: traditional medicine gets a modern twist in Iran. 2016;4: 14. Available at: http://www.theguardian.com/world/iran-blog/2016/apr/11/iran-traditional-medicine-herbs-regulation-tehranbureau

  • [24]

    Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015;13:319–25.Google Scholar

  • [25]

    Kashani L, Hassanzadeh E, Mirzabeighi A, Akhondzadeh S. Knowledge, attitude and practice of herbal remedies in a group of infertile couples. Acta Med Iran 2013;51:189–94.Google Scholar

  • [26]

    Fahimi F, Hrgovic I, El-Safadi S, Munstedt K. Complementary and alternative medicine in obstetrics: a survey from Iran. Arch Gynecol Obstet 2011;284:361–4.Google Scholar

  • [27]

    Sattari M, Dilmaghanizadeh M, Hamishehkar H, Mashayekhi SO. Self-reported use and attitudes regarding herbal medicine safety during pregnancy in Iran. Jundishapur J Nat Pharm Prod 2012;7:45.Google Scholar

  • [28]

    Tabatabaee M. Use of herbal medicine among pregnant women referring to Valiasr Hospital in Kazeroon, Fars, South of Iran. J Med Plants 2011;1:96–108.Google Scholar

  • [29]

    Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 2005;13:339–42.Google Scholar

  • [30]

    Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 2007;16:144–9.Google Scholar

  • [31]

    Harirchian MH, Sahraian MA, Hosseinkhani A, Amirzargar N. Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis. Iran J Neurol 2014;13:13.Google Scholar

  • [32]

    Yekta Z, Zamani A, Mehdizade M, Farajzadegan Z. Pattern of complementary and alternative medicine use in urban population. J Res Health Sci 2007;7:24–31.Google Scholar

  • [33]

    Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs 2007;58:307–19.Google Scholar

  • [34]

    Sina I 1037, Al-Qanoon Fit-Tib (Principles in medicine). Reprinted in 1970 from Bulaq. Lebanon: edition Sader Publishing House Beirut.Google Scholar

  • [35]

    Khorasani MA. Makhzan al Advieh. Tehran: Bavardaran Press Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, 2001.Google Scholar

  • [36]

    Khoshvaghti A, Nazifi S, Derakhshaniyan S, Akbarpour B. The effects of Zataria multiflora hydroalcoholic extract on some liver enzymes, cholesterol, triglyceride, HDL-cholesterol, LDL cholesterol, albumin and total protein in rat. J Basic Appl Sci 2012;8:217–22.Google Scholar

  • [37]

    Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med 2014;2014:642942.Google Scholar

  • [38]

    Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215–8.Google Scholar

  • [39]

    Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 2008;29:1280–4.Google Scholar

  • [40]

    Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014;65:515–20.Google Scholar

  • [41]

    Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 1992;21:526–31.Google Scholar

  • [42]

    Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007;18:179–83.Google Scholar

  • [43]

    Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2007;16:422–6.Google Scholar

  • [44]

    Kassaian N, Azadbakht L, Forghani B, Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res 2009;79:34–9.Google Scholar

  • [45]

    Rafraf M, Zemestani M, Asghari-Jafarabadi M. Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes. J Endocrinol Invest 2015;38:163–70.Google Scholar

  • [46]

    Guo YT, Lan W. Effect of uigur traditional herb matricaria chamomile extract on serum lipid of experimental hyperl ipidmia rats. J Shandong Polytech Univ (NatSci Ed) 2013;2:009.Google Scholar

  • [47]

    Solati M, Farshidfar G, Vakil MK, Saberi P, Kamalinajad M, Solati N. Effect of administration of Teucrium polium on blood glucose and lipid levels in streptozotocin-induced diabetic rats. Physiol Pharmacol. 2013;16:423–34Google Scholar

  • [48]

    Ayoubi A, Omidi A, Valizade R, Mousaei A. Effect of hydroalcoholic extract of Aloe vera and Teucrium on serum glucose and lipid profile in streptozotocin diabetic male rats. J Birjand Univ Med Sci 2013;20:144–52.Google Scholar

  • [49]

    Hosseini S, Jamshidi L, Mehrzadi S, Mohammad K, Najmizadeh AR, Alimoradi H, et al. Effects of juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2014;152:451–6.Google Scholar

  • [50]

    Kwak JS, Kwon O. The effect of walnut (Juglans regia L.) intake on improvement of blood lipid levels and vascular health: a meta-analysis. J Nutr Health 2014;47:236–46.Google Scholar

  • [51]

    Hajhashemi V, Abbasi N. Hypolipidemic activity of Anethum graveolens in rats. Phytother Res 2008;22:372–5.Google Scholar

  • [52]

    Yazdanparast R, Alavi M. Antihyperlipidaemic and antihypercholesterolaemic effects of Anethum graveolens leaves after the removal of furocoumarins. Cytobios 2001;105:185–91.Google Scholar

  • [53]

    Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis 2007;6:5.Google Scholar

  • [54]

    Daher CF, Baroody KG, Baroody GM. Effect of Urtica dioica extract intake upon blood lipid profile in the rats. Fitoterapia 2006;77:183–8.Google Scholar

About the article

Received: 2018-06-20

Accepted: 2018-10-04

Published Online: 2018-11-03


Author contributions: MHH, MS, MH and MS participated in the design of the study. MHH, SHM and MH conducted the interviews and identified all medicinal plants reported. MH contributed to the statistical analysis. SHM and MHH wrote the first draft of the manuscript. All authors contributed to interpretation of the results and the final manuscript. All authors read and approved the final manuscript.

Research funding: Fasa University of Medical Sciences (Funder Id: 10.13039/501100006402), (96133)

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Journal of Complementary and Integrative Medicine, 20180101, ISSN (Online) 1553-3840, DOI: https://doi.org/10.1515/jcim-2018-0101.

Export Citation

© 2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in